ReVision Optics, Inc.
25651 Atlantic Ocean Drive
Suite A1
Lake Forest
California
92630
United States
Tel: 949-707-2740
Fax: 949-707-2744
Website: http://www.revisionoptics.com/
Email: info@revisionoptics.com
18 articles about ReVision Optics, Inc.
-
ReVision Optics Celebrates 1,000 Raindrop Near Vision Inlay Procedures Improving Near Vision For Individuals With Presbyopia
4/4/2017
-
SoCal's ReVision Optics Nabs $32 Million for Raindrop Nearsightedness Inlay
11/11/2016
-
ReVision Optics, Inc. Announces First U.S. Commercial Cases Of Raindrop Near Vision Inlay
8/31/2016
-
ReVision Optics, Inc. Names Dr. Nick J. Manesis Vice President Of R&D
8/10/2016
-
ReVision Optics, Inc. Appoints Frank Shields Vice President Of Sales Worldwide
7/25/2016
-
FDA Approves ReVision Optics, Inc.'s Implantable Device That Changes The Shape Of The Cornea To Correct Near Vision
6/30/2016
-
Clinical Data Demonstrating Significant Improvements In Near And Intermediate Vision With ReVision Optics, Inc.’ Raindrop Near Vision Inlay Published In Journal Of Cataract Refractive Surgery
11/2/2015
-
ReVision Optics, Inc. Files Final Module Of FDA Premarket Approval Application For Raindrop Near Vision Inlay For The Correction Of Presbyopia
9/28/2015
-
ReVision Optics, Inc. and NovaMedica Sign Commercial Agreement to Market and Distribute Raindrop™ Vision Correction Technology in Russia
7/31/2013
-
ReVision Optics, Inc. Closes $55 Million Financing
7/29/2013
-
ReVision Optics, Inc. Raindrop Near Vision Inlay Featured in Presentations at the 2013 American Society of Cataract & Refractive Surgery Symposium
4/30/2013
-
ReVision Optics, Inc. Introduces Raindrop as Worldwide Brand for Its Inlay to Treat Presbyopia
9/4/2012
-
Customer Survey Shows High Satisfaction Rate With ReVision Optics, Inc.' Near Vision Inlay for Presbyopia
7/11/2012
-
ReVision Optics, Inc. Advances PresbyLens into Phase 3 Clinical Trial for Improving Near Vision in Patients with Presbyopia
6/11/2012
-
ReVision Optics, Inc. Appoints Internationally Recognized Ophthalmologist Dr. Stephen G. Slade to its Board of Directors
4/23/2012
-
ReVision Optics, Inc. Finishes Phase One of FDA Clinical Trial
9/8/2010
-
ReVision Optics, Inc. Begins U.S. Clinical Trial of the PresbyLens(R) for the Restoration of Near Vision
4/9/2010
-
ReVision Optics, Inc. Raises $25M in Series D Financing
4/30/2007